INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
63 hedge funds and large institutions have $80.2M invested in Infinity Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 64 → 63 (-1)
Holders
63
Holding in Top 10
1
Calls
$1.02M
Puts
$69K
Top Buyers
| 1 | +$1.43M | |
| 2 | +$1.33M | |
| 3 | +$879K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$745K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$542K |
Top Sellers
| 1 | -$701K | |
| 2 | -$379K | |
| 3 | -$158K | |
| 4 |
Goldman Sachs
New York
|
-$139K |
| 5 |
AG
Algert Global
San Francisco,
California
|
-$139K |